Jan'05 | Jan'06 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Jan'11 | Jan'12 | Dec'12 | Dec'13 | Dec'14 | Jan'16 | Jan'17 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $2.8 | $3.4 | $3.8 | $3.7 | $4.7 | $4.5 | $4.9 | $3.5 | $3.9 | $4.9 | $5.9 | $5.6 | $6.1 | $0.5 | $5.8 | $5.7 | $5.6 | $7.9 | $6.9 | $13.9 |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Johnson & Johnson's last 12-month EPS is $6.1, based on the financial report for Sep 29, 2024 (Q3 2024).
Over the last year, Johnson & Johnson's EPS growth was (55.2%). The average annual EPS growth rates for Johnson & Johnson have been 2.0% over the past three years, (1.2%) over the past five years.
Over the last year, Johnson & Johnson's EPS growth was (55.2%), which is lower than industry growth of (0.2%). It indicates that Johnson & Johnson's EPS growth is Bad.